midazolam serraclinics efg 50 mg 10 ampolles 10 ml
midazolam serraclinics efg 5 mg 10 ampolles 5 ml
midazolam serraclinics efg 15 mg 5 ampolles 3 ml
midazolam normon efg 5 mg/ml 5 ampolles 3 ml
midazolam normon efg 1 mg/ml 10 ampolles 5 ml
midazolam accordpharma efg 5 mg/ml 10 ampolles 10 ml
midazolam accord efg 5 mg/ml 10 ampolles 10 ml
بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.